Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment

NCT06965816 is registered in ClinicalTrials.gov with Centre Hospitalier de Saint-Denis as lead sponsor.

NCT NCT06965816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06965816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment
Lead sponsor
Centre Hospitalier de Saint-Denis
Phase
Observational
Overall status
Completed
Start date
November 24, 2022
Completion date
May 24, 2023
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, brain atrophy, cortical and subcortical atrophy, hippocampus, leukoaraiosis, magnetic resonance imaging, neurodegenerative diseases